Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731802) titled 'Finasteride and Cutibacterium' on July 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Care Provider).
Primary Sponsor: University of Washington
Condition:
Dihydrotestosterone
Periprosthetic Joint Infection (PJI)
Cutibacterium Acnes
Intervention:
Drug: Finasteride 1 mg
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: August 31, 2026
Target Sample Size: 40
To know more, visit https://clinicaltrials.gov/study/NCT07731802
Disclaimer: Curated by HT Syndication....